Heron Therapeutics Inc (NASDAQ:HRTX)
| 1.49 Delayed Data As of Dec 08 |  +0.075 / +5.32%Today’s Change | 0.50 Today|||52-Week Range 3.41 | -40.60% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 1.3M | 30.8M | 77.5M | |
| Cost of Goods Sold | 0.00 | 35.0K | 3.1M | 26.0M | ||
| Depreciation And Amortization | 734.0K | 1.1M | 1.5M | 1.5M | ||
| Operating Expenses | Gross Income | -734.0K | 145.0K | 26.2M | 50.0M | |
| General Expenses | 96.2M | 163.3M | 218.9M | 233.9M | ||
| Research And Development | 61.2M | 96.4M | 137.1M | 140.0M | ||
| Total Operating Expenses | 96.9M | 164.4M | 223.5M | 261.4M | ||
| Non-Operating Expenses | Operating Income | -96.9M | -163.1M | -192.8M | -183.9M | |
| Extraordinary Charge | 0.00 | -7.8M | -1.8M | 0.00 | ||
| Interest Expense On Debt | 958.0K | 2.7M | 3.9M | 2.7M | ||
| Other Expenses | 292.0K | 436.0K | -38.0K | 1.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -97.6M | -173.1M | -197.5M | -178.8M | |
| Net Income | -97.6M | -173.1M | -197.5M | -178.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.1M | 37.9M | 54.0M | 73.2M | |
| Shares To Calculate EPS Diluted | 33.1M | 37.9M | 54.0M | 73.2M | ||
| Earnings Per Share | EPS | -$2.95 | -$4.56 | -$3.65 | -$2.44 | |
| EPS Diluted | -$2.95 | -$4.57 | -$3.65 | -$2.44 | ||
